tiprankstipranks
Trending News
More News >
Kissei Pharmaceutical Co (KSPHF)
:KSPHF
US Market

Kissei Pharmaceutical Co (KSPHF) Income Statement

Compare
11 Followers

Kissei Pharmaceutical Co Income Statement

Last quarter (Q3 2024), Kissei Pharmaceutical Co's total revenue was ¥23.20B, an increase of 11.12% from the same quarter last year. In Q3, Kissei Pharmaceutical Co's net income was ¥3.59B. See Kissei Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 88.33B¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B
Gross Profit
¥ 44.06B¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B
Operating Expenses
¥ 38.29B¥ 33.32B¥ 33.50B¥ 32.64B¥ 31.22B
Depreciation and Amortization
¥ 4.62B¥ 4.25B¥ 4.11B¥ 3.73B¥ 3.15B
EBITDA
¥ 20.25B¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B
Operating Income
¥ 5.77B¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B
Other Income/Expenses
¥ 9.84B¥ 10.43B¥ 14.81B¥ 17.91B¥ 5.97B
Pretax Income
¥ 15.61B¥ 14.45B¥ 13.68B¥ 16.51B¥ 7.48B
Net Income
¥ 11.96B¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B
Per Share Metrics
Basic EPS
¥ 274.20¥ 246.58¥ 228.30¥ 280.19¥ 113.25
Diluted EPS
¥ 274.20¥ 246.58¥ 228.30¥ 280.19¥ 113.25
Weighted Average Shares Outstanding
43.62M 45.26M 46.12M 46.12M 46.67M
Weighted Average Shares Outstanding (Diluted)
43.62M 45.26M 46.12M 46.12M 46.67M
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis